Suppr超能文献

晶体液与胶体液在重症监护病房液体复苏中的比较:系统评价和荟萃分析。

Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: A systematic review and meta-analysis.

机构信息

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Grady Memorial Hospital, Atlanta, GA, USA.

Meridian HealthComms, Plumley Moor Road, Plumley, UK.

出版信息

J Crit Care. 2019 Apr;50:144-154. doi: 10.1016/j.jcrc.2018.11.031. Epub 2018 Nov 30.

Abstract

PURPOSE

Guidelines recommend crystalloids for fluid resuscitation in sepsis/shock and switching to albumin in cases where crystalloids are insufficient. We evaluated hemodynamic response to crystalloids/colloids in critically ill adults.

MATERIALS AND METHODS

The primary research question was: "Are crystalloids sufficient for volume replacement in severe indications (intensive care unit [ICU]/critical illness)?" Randomized, controlled trials (RCTs) were identified using PubMed and EMBASE, and screened against predefined inclusion/exclusion criteria. Meta-analyses were performed on extracted data.

RESULTS

Fifty-five RCTs (N = 27,036 patients) were eligible. Central venous pressure was significantly lower with crystalloids than with albumin, hydroxyethyl starch (HES), or gelatin (all p < .001). Mean arterial pressure was significantly lower with crystalloids vs. albumin (mean difference [MD]: -3.5 mm Hg; p = .03) or gelatin (MD: -9.2 mm Hg; p = .02). Significantly higher volumes of crystalloids were administered vs. HES (MD: +1775 mL); volume administered was numerically higher vs. albumin (MD: +1985 mL). Compared with the albumin group, cardiac index was significantly lower in the crystalloid group (MD: -0.6 L/min/m, p < .001). All mortality and 90-day mortality were significantly lower for crystalloids compared with HES (relative risk 0.91; p = .009 and 0.9; p = .005, respectively).

CONCLUSIONS

Crystalloids were less efficient than colloids at stabilizing resuscitation endpoints; guidance on when to switch is urgently required.

摘要

目的

指南建议在脓毒症/休克中使用晶体液进行液体复苏,并在晶体液不足的情况下改用白蛋白。我们评估了危重症成人对晶体液/胶体液的血流动力学反应。

材料和方法

主要研究问题是:“在严重情况下(重症监护病房[ICU]/危重病),晶体液是否足以替代容量?” 使用 PubMed 和 EMBASE 确定了随机对照试验(RCT),并根据预设的纳入/排除标准进行了筛选。对提取的数据进行了荟萃分析。

结果

符合条件的 RCT 有 55 项(N=27036 名患者)。与白蛋白、羟乙基淀粉(HES)或明胶相比,晶体液的中心静脉压明显更低(均 p<0.001)。与白蛋白相比,晶体液的平均动脉压明显更低(平均差异[MD]:-3.5mmHg;p=0.03)或明胶(MD:-9.2mmHg;p=0.02)。与 HES 相比,晶体液的给药量明显更高(MD:+1775mL);与白蛋白相比,给药量数值更高(MD:+1985mL)。与白蛋白组相比,晶体液组的心指数明显更低(MD:-0.6L/min/m,p<0.001)。与 HES 相比,所有死亡率和 90 天死亡率均明显更低(相对风险 0.91;p=0.009 和 0.9;p=0.005)。

结论

晶体液在稳定复苏终点方面的效率低于胶体液;迫切需要指导何时切换。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验